Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Castelo Branco, Morgana T L ^a   Soares, Igor D P ^a   Lopes, Daiana V ^a   Buongusto, Fernanda ^a   Martinusso, Cesonia A ^a   do Rosario, Alyson ^a   Souza, Sergio A L ^a   Gutfilen, Bianca ^a   Fonseca, Lea Mirian B ^a   Elia, Celeste ^a   Madi, Kalil ^a   Schanaider, Alberto ^a   Rossi, Maria Isabel D ^a   Souza, Heitor S P ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; COLLAGEN; CYTOKINE; TRINITROBENZENESULFONIC ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HOMING; CELL MIGRATION; CELL THERAPY; CELLULAR DISTRIBUTION; COLITIS; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE PRODUCTION; DISEASE SEVERITY; EPITHELIUM CELL; IMMUNE RESPONSE; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; RAT; SKIN FIBROBLAST; TREATMENT RESPONSE; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL LINEAGE; CELL MOTION; COLON; COLONOSCOPY; CYTOLOGY; DISEASE MODEL; INFLAMMATION; INTESTINE MUCOSA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; SUBCUTANEOUS FAT; TRANSPLANTATION; WISTAR RAT; WOUND HEALING;

RATTUS;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL LINEAGE; CELL MOVEMENT; COLITIS; COLLAGEN; COLON; COLONOSCOPY; CRYOPRESERVATION; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INTESTINAL MUCOSA; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; SUBCUTANEOUS FAT; TRINITROBENZENESULFONIC ACID; WOUND HEALING;

EID: 84858166198     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033360     Document Type: Article

References (59)

1. Podolsky DK, (2002) Inflammatory bowel disease. N Engl J Med 347 (6): 417-429.
2. Bouma G, Strober W, (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (7): 521-533.
3. Baumgart DC, Sandborn WJ, (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369 (9573): 1641-1657.
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal R, Douglas JD, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284 (5411): 143-147.
5. Da Silva Meirelles L, Sand TT, Harman RJ, Lennon DP, Caplan AI, (2009) MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A 15 (2): 221-299.
6. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, et al. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (1): 42-48.
7. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC, et al. (2005) Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19 (9): 1597-1604.
8. Aggarwal S, Pittenger MF, (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (4): 1815-1822.
9. Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A, (2009) Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8 (2): 110-123.
10. Puissant B, Barreau C, Bourin P, Clavel JC, Corre C, et al. (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129 (1): 118-129.
11. Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, et al. (2006) Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 24 (11): 582-2591.
12. Ando Y, Inaba M, Sakaguchi Y, Tsuda M, Quan GK, et al. (2008) Subcutaneous adipose tissue-derived stem cells facilitate colonic mucosal recovery from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats. Inflamm Bowel Dis 14 (6): 826-838.
13. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M, (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136 (3): 978-989.
14. Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, et al. (2009) Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58 (7): 929-939.
15. Strober W, Fuss IJ, Blumberg RS, (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20: 495-549.
16. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W, (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2 (9): 998-1004.
17. Koutroubakis IE, Tsiolakidou G, Karmiris K, Koutroubakis EA, (2006) Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 12 (6): 515-523.
18. Dignass AU, Stow JL, Babyatsky MW, (1996) Acute epithelial injury in the rat small intestine in vivo is associated with expanded expression of transforming growth factor alpha and beta. Gut 38 (5): 687-693.
19. Bazzoni F, Tamassia N, Rossato M, Cassatella MA, (2010) Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils. Eur J Immunol 40 (9): 2360-2368.
20. Hemmrich K, Meersch M, von Heimburg D, Pallua N, (2006) Applicability of the dyes CFSE, CM-DiI and PKH26 for tracking of human preadipocytes to evaluate adipose tissue engineering. Cells Tissues Organs 184 (3-4): 117-127.
21. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (4): 315-317.
22. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, et al. (2007) Stem cell transplantation: the lung barrier. Transplant Proc 39 (2): 573-576.
23. Andoh A, Bamba S, Fujiyama Y, Brittan M, Wright NA, (2005) Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol 40 (12): 1089-1099.
24. Bamba S, Lee CY, Brittan M, Preston SL, Direkze NC, et al. (2006) Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol 209 (2): 265-273.
25. Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, et al. (2007) Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 132 (3): 944-954.
26. De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, de Wever J, et al. (2007) Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92 (4): 440-449.
27. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, et al. (2004) A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104 (9): 2643-2645.
28. Rüster B, Göttig S, Ludwig RJ, Bistrian R, Müller S, et al. (2006) Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108 (12): 3938-3944.
29. Sémont A, François S, Mouiseddine M, François A, Saché A, et al. (2006) Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol 585: 19-30.
30. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, et al. (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350 (9): 876-885.
31. Nau GJ, Richmond JF, Schlesinger A, Jennings ES, Lander RA, et al. (2002) Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 99 (3): 1503-1508.
32. Li L, Zhang S, Zhang Y, Yu YX, Guan Z, (2009) Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 36 (4): 725-731.
33. Nasef A, Mathieu N, Chapel A, Frick J, François S, et al. (2007) Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84 (2): 231-237.
34. Mei SH, Haitsma JJ, Dos Santos CC, Deng PF, Lai AS, et al. (2010) Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 182 (8): 1047-1057.
35. Zarjou A, Kim J, Traylor AM, Sanders PW, Balla J, et al. (2011) Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am J Physiol Renal Physiol 300 (1): 254-262.
36. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC, (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (3): 389-397.
37. Casiraghi F, Azzollini N, Cassis P, Imberti B, Morigi M, et al. (2008) Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181 (6): 3933-3946.
38. Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, et al. (2007) Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211 (1): 121-130.
39. Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi AHaematologica, (2007) Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92 (7): 881-888.
40. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, et al. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15 (1): 42-49.
41. Bu P, Keshavarzian A, Stone DD, Liu J, Le PT, et al. (2001) Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J Immunol 166 (10): 6399-6403.
42. Yue G, Lai PS, Yin K, Sun FF, Nagele RG, et al. (2001) Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther 297 (3): 915-925.
43. Vereecke L, Sze M, Mc Guire C, Rogiers B, Chu Y, et al. (2010) Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J Exp Med 207 (7): 1513-1523.
44. Ruemmele FM, Gurbindo C, Mansour AM, Marchand R, Levy E, et al. (1998) Effects of interferon gamma on growth, apoptosis, and MHC class II expression of immature rat intestinal crypt (IEC-6) cells. J Cell Physiol 176 (1): 120-126.
45. Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, et al. (2006) Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130 (7): 1962-1974.
46. Di Sabatino A, Pender SL, Jackson CL, Prothero JD, Gordon JN, et al. (2007) Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 133 (1): 137-149.
47. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, et al. (2005) Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (8): 1128-1135.
48. Arnold F, West DC, (1991) Angiogenesis in wound healing. Pharmacol Ther 52 (3): 407-422.
49. Wu Y, Chen L, Scott PG, Tredget EE, (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25 (10): 2648-2659.
50. Marchetti M, Vignoli A, Russo L, Balducci D, Pagnoncelli M, et al. (2008) Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin. Thromb Res 121 (5): 637-645.
51. Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink R, et al. (2004) Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109: 656-663.
52. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME, (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102: 341-351.
53. Belmiro CL, Castelo-Branco MT, Melim LM, Schanaider A, Elia C, et al. (2009) Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem 284: 11267-11278.
54. Lienenluke B, Stojanovic T, Fiebig T, Fayyazi A, Germann T, et al. (2001) Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat- role of endothelial cell-leukocyte interaction. Br J Pharmacol 133 (8): 1414-1423.
55. Becker C, Fantini MC, Neurath MF, (2006) High resolution colonoscopy in live mice. Nat Protoc 1 (6): 2900-2904.
56. Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, et al. (2001) Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49: 190-198.
57. Dolber PC, Spach MS, (1993) Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 41: 465-469.
58. Carvalho AB, Quintanilha LF, Dias JV, Paredes BD, Mannheimer EG, et al. (2008) Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 26 (5): 1307-1314.
59. Barbosa da Fonseca LM, Battistella V, de Freitas GR, Gutfilen B, dos Santos Goldenberg RC, et al. (2009) Early tissue distribution of bone-marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation 120 (6): 539-541.